Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues

Clinical and Experimental Metastasis

Volumn 15, Issue 2, 1997, Pages 151-156

  Ahn, Sei Hyun ^a   Sawada, Hidetomo ^a   Ro, Jae Y ^a   Nicolson, Garth L ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b Institute for Molecular Medicine   (United States)

Author keywords

annexin; breast cancer; calcium binding protein; cell surface; immunohistochemistry

Indexed keywords

ANNEXIN 1; CALCIUM BINDING PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; TUMOR GROWTH;

ANNEXIN A1; BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; DISEASE PROGRESSION; EPITHELIUM; FEMALE; HUMANS; NEOPLASM PROTEINS;

EID: 0030979239     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018452810915     Document Type: Article

References (30)

1. Crumpton MJ and Dedman JR, 1990, Protein terminology tangle. Nature, 345, 212.
2. Crompton MR, Moss SE and Crumpton MJ, 1988, Diversity in the lipocortin/calpactin family. Cell, 55, 1-3.
3. Pepinsky RB, Tizard R, Mattaliano RJ, et al. 1988, Five distinct calcium and phospholipid binding proteins share homology with lipocortin I. J Biol Chem, 263, 10799-811.
4. 2+ and phospholipid binding domains. Biochem Biophys Res Commun, 200, 867-76.
5. Burgoyne RD and Geisow MJ, 1989, The annexin family of calcium-binding proteins. Cell Calcium, 10, 1-10.
6. Hoekstra D, Buist-Arkema R, Klappe K and Reutelingsperger CP, 1993, Interaction of annexins with membranes: the N-terminus as a governing parameter as revealed with a chimeric annexin. Biochemistry, 32, 14194-202.
7. Klee CB, 1988, Calcium dependent phospholipid and membrane binding proteins. Biochemistry, 27, 6645-53.
8. Futter CE, Felder S, Schlessinger J, Ullrich A and Hopkins CR, 1993, Annexin I is phosphorylated in the multivesicular body during the processing of the epidermal growth factor receptor. J Cell Biol, 120, 77-83.
9. Oudinet JP, Russomarie F, Cavadore JC and Rothhut B, 1993, Protein kinase C-dependent phosphorylation of annexins I and II in mesangeal cells. Biochem J, 292, 63-8.
10. Michener ML, Dawson WB and Creutz CE, 1986, Phosphorylation of a chromaffin granule-binding protein in stimulated chromaffin cells. J Biol Chem, 261, 6548-55.
11. Masaki T, Tokuda M, Fujimura T, et al. 1994, Involvement of annexin I and annexin II in hepatocyte proliferation: can annexins I and II be markers for proliferative hepatocytes? Hepatology, 20, 425-35.
12. Wong WT, Nick HS and Forst SC, 1992, Regulation of annexin I in adipogenesis: cAMP-independent action of methylisobutylxanthine. Am J Physiol, 262, 91-7.
13. Lozano JJ, Siberstein GB, Hwang SI, Haindl AH and Rocha V, 1989, Developmental regulation of calcium binding proteins (calelectrins and calpactin I) in mammary gland. J Cell Physiol, 138, 503-10.
14. Horlick KR, Ganjianpour M, Frost SC and Nick HS, 1991, Annexin I regulation in response to suckling and rat mammary cell differentiation. Endocrinology, 128, 1574-9.
15. Creutz CE, Kambouris NG, Snyder SL, et al. 1992, Effects of the expression of mammalian annexins in yeast secretory mutants. J Cell Sci, 103, 1177-92.
16. Raynal P, Van Bergen en Henegouwen PMP, Hullin F, el al. 1992, Morphological and biochemical evidence for partial nuclear localization of annexin I in endothelial cells. Biochem Biophys Res Commun, 186, 432-9.
17. Naritoku WY and Taylor CR, 1988, A comparative study of the use of monoclonal antibodies using three different immunohistochemical methods. J Histochem Cytochem, 30, 253-60.
18. Zokas L and Glenney Jr JR, 1987, The calpactin light chain is tightly linked to the cytoskeleton form of calpactin I; studies using monoclonal antibodies to calpactin subunits. J Cell Biol, 105, 2111-20.
19. +2 binding and phosphorylation by the epidermal growth factor receptor in vitro. Biochemistry, 27, 2069-76.
20. Woods GS and Warnke R, 1981, Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection system. J Histochem Cytochem, 29, 1196-204.
21. Wong WT, Frost SC and Nick HS, 1991, Protein-synthesis-dependent induction of annexin I by glucocorticoid. Biochem J, 275, 313-9.
22. Violette SM, King I, Browning JL, Pepinsky RB, Wallner BP and Sartorelli AC, 1990, Role of lipocortin I in the glucocorticoid induction of the terminal differentiation of a human squamous carcinoma. J Cell Physiol, 142, 70-7.
23. Pencil SD, Toh Y and Nicolson GL, 1993, Candidate metastasis-associated genes of the rat 13762NF mammary adenocarcinoma. Breast Cancer Res Treatm, 25, 165-74.
24. Toh Y, Pencil SD and Nicolson GL, 1994, A novel candidate metastasis-associated gene mtal differentially expressed in highly metastatic mammary adenocarcinoma cell lines: cDNA cloning, expression and protein analyses. J Biol Chem, 269, 22958-63.
25. Yeatman TJ, Updyke TV, Kaetzel MA, Dedman JR and Nicolson GL, 1993, Expression of annexins on the surfaces of non-metastatic and metastatic human and rodent tumor cells. Clin Exp Metastasis, 11, 37-44.
26. Nicolson GL, 1991, Quantitative variations in gene expression: possible role in cellular diversification and tumor progression. J Cell Biochem, 46, 277-83.
27. Nicolson GL, 1991, Gene expression and tumor progression to the metastatic phenotype. Bioessays, 13, 337-42.
28. Tressler RJ, Updyke TV, Yeatman TJ and Nicolson GL, 1993, Extracellular annexin II is associated with divalent cation-dependent tumor cell-endothelial cell adhesion of metastatic RAW 117 large-cell lymphoma cells. J Cell Biochem, 53, 265-76.
29. Tressler RJ, Updyke TV, Yeatman T and Nicolson GL, 1994, Extracellular annexin VI is associated with divalent cation-dependent endothelial cell adhesion of metastatic RAW117 large-cell lymphoma cells. Exp Cell Res, 215, 395-400.
30. Schwartz-Albiez R, Koretz K, Moller P and Wirl G, 1993, Differential expression of annexins I and II in normal and malignant human mammary epithelial cells. Differentiation, 52, 229-37.